Shanghai OPM Biosciences Co., Ltd. provides cell culture media and CDMO services in China and internationally. The company offers OPM cell culture media services, including OPM-CHO platform, OPM-293 platform, OPM-VAC platform, OPM-Hybri platform, and classical media; customized media solutions; and OEM media manufacturing services. It also provides end-to-end biologics CDMO services, such as antibody discovery, stable cell line development & cell banking platform, upstream process development, downstream process development, OPM formulation development platform, quality control and product characterization of biologics, and pilot scale production services. The company was founded in 2013 and is headquartered in Shanghai, China.
Stock data | 2024 | Change |
---|---|---|
Price | $5.47 | N/A |
Market Cap | $627.54M | N/A |
Shares Outstanding | 114.77M | N/A |
Employees | 261.00 | N/A |